Description
Class C07J : STEROIDS
Subclass 15/00: Stereochemically pure steroids containing carbon, hydrogen, halogen, or oxygen, having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
C07J 15/00
Sub-Class
Stats
- 12 US PATENTS IN FORCE
- 3 US APPLICATIONS PENDING
- 3 Total Patent Owners
- 31 TOTAL INVENTORS
Recent Patents
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 12201640 | 19-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereof | Dec 23, 21 | Jan 21, 25 | SAGE THERAPEUTICS, INC. |
| 11459353 | Steroids and methods of manufacture | Aug 16, 18 | Oct 04, 22 | The Trustees of Dartmouth College |
| 11344563 | 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof | Jul 10, 19 | May 31, 22 | SAGE THERAPEUTICS, INC. |
| 11241446 | 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof | May 31, 19 | Feb 08, 22 | SAGE THERAPEUTICS, INC. |
| 10654885 | Process for the preparation of 9 beta,10 alpha-progesterone (retroprogesterone) | Jan 18, 18 | May 19, 20 | INDUSTRIALE CHIMCA S.R.L. |
| 10391106 | 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof | Jun 30, 17 | Aug 27, 19 | SAGE THERAPEUTICS, INC. |
| 10342810 | 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof | Jun 27, 18 | Jul 09, 19 | SAGE THERAPEUTICS, INC. |
| 10202413 | Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for GABA type-A receptors | Feb 14, 14 | Feb 12, 19 | Washington University |
| 10172871 | 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof | Oct 19, 16 | Jan 08, 19 | SAGE THERAPEUTICS, INC. |
| 9896474 | (3A,9B,10A,13A,14B,17A,20S,22E)-ergosta-5,7,22-trien-3-ol and methods of preparing and using the same | Aug 03, 16 | Feb 20, 18 | ZHENGYUANTANG (TIANJIN BINHAI NEW AREA) BIOTECH CO., LTD. |
| 9855281 | Libido-enhancing therapeutic and use | Nov 20, 14 | Jan 02, 18 | Scott Freeman Consultant, LLC |
| 9512165 | 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof | Apr 17, 14 | Dec 06, 16 | SAGE THERAPEUTICS, INC. |
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2024/0409,576 | -ent-19-norprogesterone, compositions and uses thereof to treat traumatic brain injury (TBI), including concussions- | May 30, 23 | Dec 12, 24 | Oragenics, Inc |
| 2024/0228,527 | STEREOSELECTIVE C9-C10 BOND FORMATION | Apr 14, 22 | Jul 11, 24 | Not available |
| 2020/0040,029 | PROCESS FOR THE PREPARATION OF 9 BETA,10 ALPHA-PROGESTERONE (RETROPROGESTERONE) | Jan 18, 18 | Feb 06, 20 | Not available |
Top Owners in This Subclass
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 27 Months (last 2 years Issuances)
- 27 Months (last 5 years Issuances)